Cartesian Therapeutics
RNAC
RNAC
84 hedge funds and large institutions have $63.3M invested in Cartesian Therapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-12
Holders Change %
-12.5%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
17
Reduced
33
Closed
17
Calls
$18K
Puts
$48K
Net Calls
-$30K
Net Calls Change
-$376K
Top Buyers
| 1 |
ABG
Ally Bridge Group
New York
|
$2.89M |
| 2 |
DFG
Delphi Financial Group
Wilmington,
Delaware
|
$747K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
$1.89M |
| 4 |
Renaissance Technologies
New York
|
$1.38M |
| 5 |
Citigroup
New York
|
$343K |
